Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-25 @ 7:23 PM
NCT ID:
NCT03181932
Group ID:
EG000
Title:
Double-blind Vancomycin Inhalation Powder
Description:
Vancomycin inhalation powder 30 mg is administered twice daily (BID) during the 24-week double-blind period (Period 1) by inhalation during three dosing cycles, each cycle being 28 days of treatment followed by 28 days of observation.
Vancomycin inhalation powder: 100 participants are to be treated with double-blind vancomycin inhalation powder (75 participants ≤21 years old, 25 participants \>21 years old) for 24 weeks during Period 1.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
24
Serious Number At Risk:
90
Other Number Affected:
85
Other Number At Risk:
90
Study:
NCT03181932
Results Section:
NCT03181932
Adverse Events Module:
NCT03181932